Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer

Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival for mCRC patient led to two main outstanding issues: 1) there is a significant number of pat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tonini, Giuseppe, Imperatori, Marco, Vincenzi, Bruno, Frezza, Anna Maria, Santini, Daniele
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874688/
https://ncbi.nlm.nih.gov/pubmed/24245912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-92
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki